Mendelian randomization of immune cell phenotypes to discover potential drug targets for B-cell malignancy

Abstract Although treatment options for B-cell malignancies have expanded, many patients continue to face limited response rates, highlighting an urgent need for new therapeutic targets. To prioritize candidate drug targets for B-cell malignancies, we employed Mendelian Randomization to estimate pot...

Full description

Saved in:
Bibliographic Details
Main Authors: Sina A. Beer, Molly Went, Charlie Mills, Codie Wood, Amit Sud, James M. Allan, Richard Houlston, Martin F. Kaiser
Format: Article
Language:English
Published: Nature Publishing Group 2025-04-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-025-01277-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items